THE DEVELOPMENT OF ACUTE HEMOLYTIC ANEMIA

Publisher Website
Google Scholar
Abstract
The use of sulfanilamide (para-aminobenzenesulfonamide) in the treatment of various bacterial infections, notably those caused by the hemolytic streptococcus, is rapidly becoming widespread owing to the favorable reports published first by Domagk in Germany,1then by Colebrook in England,2and recently by Long and Bliss3in the United States. Certain minor toxic effects of the drug have been noted; namely, a depression of liver function as determined by the bromsulfalein excretion test, fever, cyanosis and mild acidosis;4but thus far no toxic effects of alarming proportions have been described in the literature. That a drug with such close chemical relationship to aniline might have a very serious effect on the blood and bone marrow has undoubtedly been in the minds of many, and in this clinic patients have been rather carefully watched for the appearance of such phenomena. During five months of intensive use of sulfanilamide

This publication has 0 references indexed in Scilit: